The 20 Best Squamous Cell Lung Carcinoma Doctors near Dallas, TX

. Dr. Soriano is rated as an Experienced provider by MediFind in the treatment of Squamous Cell Lung Carcinoma. Her top areas of expertise are Obstructive Sleep Apnea, Chronic Obstructive Pulmonary Disease (COPD), Pneumonia, Lung Metastases, and Gastrostomy.

Dr. Konduri attended medical school at the University College of Medical Sciences-India. He then completed a residency in Internal Medicine at Rush Presbyterian St Luke's - Westlake Residency Program, Melrose Park, Illinois, followed by a fellowship in Medical Oncology at Baylor University Medical Center, part of Baylor Scott & White Health. Dr. Konduri is certified in Internal Medicine and in Medical Oncology by the American Board of Internal Medicine. He specializes in medical oncology with a particular interest in lung and thoracic oncology. Dr. Konduri is rated as a Distinguished provider by MediFind in the treatment of Squamous Cell Lung Carcinoma. His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Lung Adenocarcinoma, and ALK-Positive Non-Small Cell Lung Cancer.

Inderpal Sarkaria is a General Surgeon and a Thoracic Surgeon in Dallas, Texas. Dr. Sarkaria is rated as a Distinguished provider by MediFind in the treatment of Squamous Cell Lung Carcinoma. His top areas of expertise are Esophageal Cancer, Hiatal Hernia, Lung Cancer, Thymectomy, and Endoscopy.

Dr. Nadler specializes in medical oncology. He serves as a Medical Director of US Oncology Health Informatics and Internet Technology. He remains active in USON research committees in lung cancer, head and neck cancer, and sarcoma within the developmental committees. Dr. Nadler received a BA with highest honors from Wesleyan University double majoring in molecular biology and philosophy. He received his joint MD/MPP from Harvard Medical School and a Master in Public Policy from Harvard University's Kennedy School of Government. Dr. Nadler then completed his internship and residency in Boston, MA, at Brigham and Women's Hospital in Boston and his oncology fellowship at Dana Farber Cancer Institute/MGH. Dr. Nadler is rated as an Advanced provider by MediFind in the treatment of Squamous Cell Lung Carcinoma. His top areas of expertise are Lung Cancer, Adenoid Cystic Carcinoma, Bone Tumor, and Pleuropulmonary Blastoma.

Dr. Schwartz is a thoracic surgeon with expertise in thoracic oncology, minimally invasive thoracic surgery, airway surgery, lung transplantation and extracorporeal membrane oxygenation. He completed a year of research focusing on thoracic oncology and endoscopic airway interventions. He has published many peer-reviewed publications and earned multiple clinical awards, including Chief Resident of the Year and the Charles McBurney Award. In addition, Dr. Schwartz serves in the following roles at Baylor University Medical Center: Chief, Department of Thoracic Surgery; Surgical Director, Lung Transplantation; Medical Director, Extracorporeal Membrane Oxygenation; and Surgical Director, Major Airway Disorders. He is married with four children and enjoys traveling, cooking, swimming and yoga. See Dr. Schwartz's Publications. Dr. Schwartz is rated as an Advanced provider by MediFind in the treatment of Squamous Cell Lung Carcinoma. His top areas of expertise are Lung Nodules, Pleuropulmonary Blastoma, Lung Cancer, Lung Transplant, and Gastrostomy.

Dr. Kummerfeldt specializes in pulmonary and critical care medicine. He is experienced the treatment of general pulmonary conditions such as pleural effusions, asthma, COPD, pulmonary nodules, cough and interstitial lung disease. He has a professional interest in pleural disease, thoracic and critical care ultrasound. Dr. Kummerfeldt is rated as an Advanced provider by MediFind in the treatment of Squamous Cell Lung Carcinoma. His top areas of expertise are Chronic Obstructive Pulmonary Disease (COPD), Lung Metastases, Lung Nodules, Advanced Bronchoscopy, and Gastrostomy.

David Mason is a General Surgeon and a Thoracic Surgeon in Dallas, Texas. Dr. Mason is rated as an Advanced provider by MediFind in the treatment of Squamous Cell Lung Carcinoma. His top areas of expertise are Pleuropulmonary Blastoma, Lung Cancer, EGFR Positive Lung Cancer, Gastrostomy, and Endoscopy.

Jonathan Dowell is a Hematologist in Dallas, Texas. Dr. Dowell is rated as a Distinguished provider by MediFind in the treatment of Squamous Cell Lung Carcinoma. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Mesothelioma, and EGFR Positive Lung Cancer.

Dr. Roberts is a board-certified cardiovascular surgeon specializing in coronary and aortic surgery. After completing his undergraduate studies at Vanderbilt University and obtaining his medical degree from Emory University, Dr. Roberts trained in thoracic and cardiovascular surgery at The University of North Carolina at Chapel Hill (1993-1996). He then spent a year in London at the Royal Bromptom Hospital for advanced training in cardiovascular surgery. Dr. Roberts came to Baylor University Medical Center in 2018, after 20 years in academic and private practice. Since then, he has served as Medical Director of Cardiovascular Research and Education (2018-2022), Chair of the Department of Cardiac Surgery (2018-2022) and Chief of Cardiovascular Quality (2024-present). He is also a Professor of Surgery affiliated with Texas A&M School of Medicine. In addition, he has published more than 125 medical articles and 5 books related to his field. Dr. Roberts has a special interest in coronary artery disease, aortic aneurysms and aortic dissection. He is dedicated to his family, to his profession, and to his patients. Dr. Roberts is rated as an Experienced provider by MediFind in the treatment of Squamous Cell Lung Carcinoma. His top areas of expertise are Aortic Dissection, Thoracic Aortic Aneurysm, Cystic Medial Necrosis of Aorta, Heart Bypass Surgery, and Aortic Valve Replacement.

Robert Mennel is an Internal Medicine specialist and an Oncologist in Dallas, Texas. Dr. Mennel is rated as an Experienced provider by MediFind in the treatment of Squamous Cell Lung Carcinoma. His top areas of expertise are Angiosarcoma, Adult Soft Tissue Sarcoma, Angiosarcoma of the Scalp, and Mesenchymoma.

Dr. Kelly received his medical degree from the Royal College of Surgeons in Ireland in 1998. He completed his internship, residency and oncology fellowship from the Royal College of Physicians in Ireland in 2007. Dr. Kelly completed a second fellowship in medical oncology at the National Cancer Institute (NCI) in Bethesda MD from 2007–2009 and continued as a clinical researcher in thoracic oncology at the NCI until moving to Johns Hopkins in 2011. At Johns Hopkins, Dr. Kelly was the director of the gastroesophageal cancer therapeutics program and also served as the director of global oncology for Johns Hopkins International. Dr. Kelly was recruited as the Director of Oncology for the Charles A. Sammons Cancer Center and the Chief of Oncology for the North Texas Division of the BSWH system in 2018. Dr. Kelly performs translational and clinical research encompassing the discovery and the development of new targeted and immunotherapeutic approaches in the prevention and treatment of gastroesophageal cancer and lung cancer and he is the International principal investigator on a number of global phase II/III clinical trials in these disease areas. In addition he is leading efforts nationally and internationally to design quality metrics for solid tumors and implementing value-based algorithms to help bend the cost curve in the United States. At the Charles A. Sammons Cancer Center he also helps to co-lead the Innovative Clinical Trials Center which investigates novel therapeutics across a range of tumor types. He serves as the co-chair of the International Association for the Study of Lung Cancer (IASLC) and the American Society of Clinical Oncology (ASCO) taskforce working to improve the quality of care received by lung cancer patients worldwide. He is an active member of ASCO and the Eastern Cooperative Oncology group. He is a founding member of the International Quality Oncology Taskforce in ASCO and serves on the ASCO measures taskforce, the clinical practice committee and the lung cancer quality taskforce. He has authored and co-authored over 150 peer-reviewed publications, abstracts and book chapters, and contributed his work to many prominent healthcare journals. Dr. Kelly’s leadership of oncology services spans Baylor Scott & White’s footprint in the Dallas-Fort Worth area, which includes Baylor University Medical Center—the System’s North Texas flagship hospital and one of the largest cancer hospitals in the nation—as well as a network of 11 Baylor Charles A. Sammons Cancer Centers throughout Texas. Publications. Dr. Kelly is rated as an Experienced provider by MediFind in the treatment of Squamous Cell Lung Carcinoma. His top areas of expertise are Esophageal Cancer, Gastroesophageal Junction Cancer, Non-Small Cell Lung Cancer (NSCLC), Pancreaticoduodenectomy, and Tissue Biopsy.

"""Dr. Denham specializes in Hematology and Medical Oncology. He is board certified in Medical Oncology and Internal Medicine. Dr. Denham is a Diplomate of the American Board of Internal Medicine with subspecialty certification in Medical Oncology.""". Dr. Denham is rated as an Experienced provider by MediFind in the treatment of Squamous Cell Lung Carcinoma. His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Bone Tumor, Mesothelioma, and Thymectomy.

Dr. Scruggs has clinical interest in brachytherapy, IMRT and stereotactic radiosurgery. He graduated magna cum laude from The University of Mississippi with a BA in physics in 1998. He earned his medical degree and completed an internship in internal medicine at the University of Texas Medical Branch in Galveston in 2003. Dr. Scruggs completed his radiation oncology residency training at The Ohio State University in 2007. Dr. Scruggs is rated as an Experienced provider by MediFind in the treatment of Squamous Cell Lung Carcinoma. His top areas of expertise are Pleuropulmonary Blastoma, Cervical Cancer, Neuroendocrine Carcinoma of the Cervix, and Lung Cancer.

Dr. Coyle specializes in Medical Oncology and Hematology. She is a Diplomate of the American Board of Internal Medicine with board certifications in Medical Oncology, Hematology and Internal Medicine.Dr. Coyle focuses on the treatment of gastrointestinal and thoracic malignancies. She is also the medical director for oncology outpatient services at the Baylor T. Boone Pickens Cancer Hospital in Dallas and is a member of the US Oncology Network (USON) Research Gastrointestinal and Lung Committees. Dr. Coyle is rated as an Experienced provider by MediFind in the treatment of Squamous Cell Lung Carcinoma. Her top areas of expertise are Familial Colorectal Cancer, Anal Cancer, Lynch Syndrome, and Colorectal Cancer.

Charles Cowey is a Hematologist and an Oncologist in Dallas, Texas. Dr. Cowey is rated as an Experienced provider by MediFind in the treatment of Squamous Cell Lung Carcinoma. His top areas of expertise are Melanoma, Merkel Cell Carcinoma, Renal Cell Carcinoma (RCC), and Basal Cell Skin Cancer.

Dr. Paulson is board certified in Medical Oncology and Internal Medicine. He serves as the co-director of the Gastrointestinal Research Program for The US Oncology Network, as well as the medical director for the Neuroendocrine Research and Treatment Center at Baylor Charles A. Sammons Cancer Center.Dr. Paulson is active in clinical research focused on neuroendocrine tumors, as well as cancers of the pancreas, liver, esophagus, stomach and colon. Dr. Paulson is rated as an Experienced provider by MediFind in the treatment of Squamous Cell Lung Carcinoma. His top areas of expertise are Neuroendocrine Tumor, Pancreatic Cancer, Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET), Gastrostomy, and Endoscopy.

Dr. Podgaetz has a professional goal to identify the best treatments for his patients - tailoring therapy by considering not only the disease, but also the personal situation of each patient and family. Dr. Podgaetz completed medical school at La Salle University School of Medicine in Mexico City. He moved to the United States to complete his internship in general surgery at Mayo Clinic in Rochester, Minnesota. From there he continued his training at Mayo Clinic and George Washing University in Washington D.C. It was there he found interest in thoracic oncology, treating pulmonary, esophageal and mediastinal tumors leading him to complete a fellowship in cardiothoracic surgery at Massachusetts General Hospital in Boston, MA. Dr. Podgaetz believes and promotes the benefits of minimally invasive thoracic surgery (VATS and Robotic) for his patients as this helps accelerate recovery, minimize pain and shorten hospital stay. One of his areas of interest is Enhanced Recovery After Surgery (ERAS) for thoracic surgery. This multimodal strategy synergistically helps patients recover faster and regain their full preoperative functional status sooner. He has been teaching since 2003 and is committed to surgical education, helping new generations of young surgeons learn and become proficient in thoracic surgery diseases. Dr. Podgaetz has authored multiple peer reviewed publications, articles, chapters, abstract and presentations at national and international meetings. He enjoys spending time with family, traveling, cycling and reading/audiobooks. See Dr. Podgaetz’s Publications. Dr. Podgaetz is rated as an Experienced provider by MediFind in the treatment of Squamous Cell Lung Carcinoma. His top areas of expertise are Achalasia, Esophageal Perforation, Pleuropulmonary Blastoma, Endoscopy, and Gastrostomy.

Dr. Kumar is a fellowship-trained and board-certified interventional pulmonologist with expertise in a wide range of minimally invasive pulmonary procedures. He has a particular focus on lung cancer diagnostic and procedural interventions, bronchoscopic lung volume reduction (BLVR) for COPD, ultrasound-guided pulmonary procedures, and both benign and malignant pleural diseases. In addition to his clinical practice, Dr. Kumar serves as the medical director of interventional pulmonology at Baylor University Medical Center, part of Baylor Scott & White Health. When his busy schedule allows, Dr. Kumar enjoys playing badminton, table tennis, pool, swimming, watching movies or sports, traveling, and spending quality time with his family and friends. Dr. Kumar is rated as an Experienced provider by MediFind in the treatment of Squamous Cell Lung Carcinoma. His top areas of expertise are Lung Metastases, Chronic Obstructive Pulmonary Disease (COPD), Emphysema, Lung Nodules, and Advanced Bronchoscopy.

Dr. Alkhatib is a dedicated pulmonary and critical care medicine physician with a specialized interest in interstitial lung diseases. He completed his training in pulmonary and critical care at Tulane University, where he was actively involved in both basic and clinical research in the field of interstitial lung diseases. Throughout his career, Dr. Alkhatib has authored several published peer-reviewed articles that have contributed to advancing knowledge and treatment in this area. Outside of medicine, he enjoys watching basketball and pursuing astrophotography whenever the sky is clear, capturing the wonders of the universe. Dr. Alkhatib is rated as an Experienced provider by MediFind in the treatment of Squamous Cell Lung Carcinoma. His top areas of expertise are Interstitial Lung Disease, Acute Interstitial Pneumonia, Lung Metastases, and Pneumonia.

Frank Brancaccio is an Internal Medicine specialist and an Intensive Care Medicine provider in Dallas, Texas. Dr. Brancaccio is rated as an Experienced provider by MediFind in the treatment of Squamous Cell Lung Carcinoma. His top areas of expertise are Hospital-Acquired Pneumonia, Atypical Pneumonia, Lung Metastases, Chronic Obstructive Pulmonary Disease (COPD), and Bone Marrow Aspiration.